Myriad Genetics · 21 hours ago
Computational Scientist II
United States
Full-time
Remote
Mid LevelMyriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being through genetics. The Computational Scientist II will design, build, and launch genomic products that improve patients’ lives, while collaborating with various scientific teams and communicating results to stakeholders.
BiotechnologyPharmaceuticalPrecision Medicine
Responsibilities
Author optimized and reliable analysis pipelines applied to samples
Rigorously analyze a variety of big datasets to gain actionable insights launched into the lab
Amplify the productivity of the entire R&D team by creating time-saving software tools and environments
Work on collaborative teams with experimental scientists, software engineers, automation engineers, and data scientists
Communicate results internally to key stakeholders and externally at conferences and in peer-reviewed literature
Qualification
Required
PhD (or master's degree with relevant experience) in bioinformatics, computational biology, computer science, biophysics, physics, statistics, molecular biology, genetics, or related discipline required
Conversant in molecular biology and genetics
Exceptional software skills, preferably with fluency in Python
Impeccable integrity and palpable drive, with the competency to be self-sufficient and a strong desire to be part of a supportive team
Preferred
Experience with Next Generation Sequencing
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
Founded in 1991
1001-5000 employees
H1B Sponsorship
Myriad Genetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (9)
2023 (4)
2022 (7)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Leadership Team
Sam Raha
CEO | President | Board member
Ben Wheeler
Chief Financial Officer
Recent News
Company data provided by crunchbase